Allogenetics

Allogenetics

Phase 1
Berlin, GermanyFounded 2021allogenetics.de

Our vision is a completely new approach to solving the problem of organ rejection: instead of inducing immunological blindness in the organ recipient, an immunological invisibility of the donor organ will be created – for a life without rejection and immunosuppression, better graft survival, better quality of life and more available organs.

Founded
2021
Focus
BiologicsTissue Engineering

About

Our vision is a completely new approach to solving the problem of organ rejection: instead of inducing immunological blindness in the organ recipient, an immunological invisibility of the donor organ will be created – for a life without rejection and immunosuppression, better graft survival, better quality of life and more available organs.

Funding History

1

Total raised: $1.5M

Seed$1.5MHigh-Tech GründerfondsMay 15, 2022

Company Info

TypePrivate
Founded2021
LocationBerlin, Germany
StagePhase 1
SIMILAR COMPANIES
300Microns
300Microns
Pre-clinical · Munich
BetaSense
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Mireca Medicines
Pre-clinical · Munich
Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.

Claim profile